New Delhi, Oct 26 (PTI) Drugmaker Sanofi India on Tuesday reported a net profit of Rs 529.8 crore for the third quarter ended September 30, aided by Rs 489.2 crore gain from the sale of its nutraceuticals business.

The company had reported a net profit of Rs 132.9 crore in the July-September quarter of the previous fiscal, Sanofi India said in a regulatory filing.

Also Read | How To Log In To Your WhatsApp on PC/Laptop.

Sanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to Universal Nutriscience for a consideration of Rs 587 crore.

The transaction was closed on September 27.

Also Read | Moto G200 Specifications Reportedly Emerge Online, Likely To Come With 108MP Camera & Snapdragon 888 SoC.

During the period under review, the company has accounted for a gain of Rs 489.2 crore from the transaction, which was disclosed as an exceptional item.

The company's revenue from operations rose to Rs 754.5 crore as compared to Rs 686.6 crore in the year-ago period.

Sanofi follows a January-December financial year.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)